Epichem CEO, Colin La Galia, resigns
PERTH, AUSTRALIA: PharmAust Limited (ASX: PAA & PAAO), a clinical stage biotechnology company, announced that Colin La Galia, Chief Executive Officer (CEO) of PAA’s subsidiary Epichem, has resigned. La Galia will leave Epichem on 23 March 2022 to pursue another…